(19)
(11) EP 4 391 886 A1

(12)

(43) Date of publication:
03.07.2024 Bulletin 2024/27

(21) Application number: 22765229.4

(22) Date of filing: 19.08.2022
(51) International Patent Classification (IPC): 
A61B 5/00(2006.01)
A61B 5/349(2021.01)
A61N 1/37(2006.01)
A61B 5/0205(2006.01)
A61B 5/346(2021.01)
A61N 1/365(2006.01)
G16H 50/30(2018.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/365; G16H 50/30; A61B 2560/0209; A61B 5/361; A61B 5/363; A61B 5/686; A61B 5/4839; G16H 20/30; A61N 1/36114; A61N 1/3621; A61N 1/3987
(86) International application number:
PCT/IB2022/057804
(87) International publication number:
WO 2023/026157 (02.03.2023 Gazette 2023/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.08.2021 US 202163237747 P
19.07.2022 US 202217813393

(71) Applicant: Medtronic, Inc.
Minneapolis, Minnesota 55432 (US)

(72) Inventor:
  • ZHOU, Xiaohong
    Minneapolis, Minnesota 55432 (US)

(74) Representative: Zimmermann & Partner Patentanwälte mbB 
Postfach 330 920
80069 München
80069 München (DE)

   


(54) TWO STAGE RISK ASSESSMENT FOR PREDICTING IMMINENT ACUTE CARDIAC EPISODES